Abstract:BACKGROUND:Chronic allograft nephropathy (CAN) is a leading cause of kidney graft failure. The latest evidence suggests that connective tissue growth factor (CTGF) may be a biomarker of CAN. Detection of urinary CTGF levels is a potential noninvasive strategy to predict the early onset of CAN. Compared to the traditional "sandwich" enzyme-linked immunosorbent assay (ELISA), we established a novel, accurate, faster, one-step competitive indirect ELISA (Ci-ELISA) to estimate the urinary CTGF concentrations in humans, rats, and mice.MATERIALS AND METHODS:We used recombinant human CTGF, which is an 11.2 kDa protein of 98 amino acid residues containing the C-terminal portion of the full-length CTGF protein having 96% and 94% homology with rats and mice, as the coating antigen and standard competitor. We then applied polyclonal antibody against the CTGF C-terminal portion, secondary antibody conjugated with horseradish peroxidase (HRP), and urine samples to establish one-step Ci-ELISA. Rat kidney allograft recipients were sacrificed at 4, 8, or 12 weeks posttransplantation. We harvested serum, urine, and transplanted kidneys. Hematoxylin-eosin (H&E), periodic acid-Schiff (PAS), and Masson trichrome stains were used to estimate the histopathologic changes according to the Banff schema. Serum creatinine (SCr) levels were measured to represent renal function. CTGF in kidney was detected by immunohistochemistry. Urinary CTGF concentrations were measured using the one-step Ci-ELISA.RESULTS:The whole one-step Ci-ELISA test can be accomplished within 2 hours. The detection limit of the assay was 0.16 ng/mL CTGF. The time-dependent elevated recipient concentration of urinary CTGF was positively correlated with SCr, histologic changes, and CTGF in the kidney after transplantation. The 95% confidence intervals of urinary CTGF concentrations in control rats were 24.4 to 35.2 ng/mL; at 4, 8, and 12 weeks posttransplantation they were 139.4 to 395.6, 826.7 to 1429.5, and 3206.0 to 4448.2 ng/mL, respectively.CONCLUSIONS:A rapid one-step Ci-ELISA was successfully established to detect the CTGF levels in urine. These results further indicated that detection of urinary CTGF is a potential noninvasive strategy to predict the early onset of CAN.

Point-of-care non-invasive enzyme-cleavable nanosensors for acute transplant rejection detection

Granzyme B-responsive Fluorescent Probe for Non-Invasive Early Diagnosis of Transplant Rejection.

Non-invasive detection of acute renal allograft rejection by measurement of vascular endothelial growth factor in urine.

Noninvasive Early Diagnosis of Allograft Rejection by a Granzyme B Protease Responsive NIR‐II Bioimaging Nanosensor

Artificial Urinary Biomarkers for Early Diagnosis of Acute Renal Allograft Rejection

Biomarkers for Renal Transplantation: Where Are We?

Prediction of Subclinical Renal Allograft Rejection by Vascular Endothelial Growth Factor in Serum and Urine.

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

Biomimetic Glucan Particles with Aggregation-Induced Emission Characteristics for Noninvasive Monitoring of Transplant Immune Response

Ultrasound Molecular Imaging of Acute Cardiac Transplantation Rejection Using Nanobubbles Targeted to T Lymphocytes

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

Target-Initiated Great Change in Electrochemical Steric Hindrance for an Assay of Granzyme B Activity

Feasibility of Diagnosing Renal Allograft Dysfunction by Oligonucleotide Array: Gene Expression Profile Correlates with Histopathology.

Implantable bioelectronic systems for early detection of kidney transplant rejection

Noninvasive quantification of granzyme B in cardiac allograft rejection using targeted ultrasound imaging

GC/MS-based Urine Metabolomics Analysis of Renal Allograft Recipients with Acute Rejection

Biomarkers from subcutaneous engineered tissues predict acute rejection of organ allografts

Novel non-invasive method for urine mapping: Deep-learning-enabled SERS spectroscopy for the rapid differential detection of kidney allograft injury

Developing Renal Allograft Surveillance Strategies – Urinary Biomarkers of Cellular Rejection

A Novel Accurate Rapid ELISA for Detection of Urinary Connective Tissue Growth Factor, a Biomarker of Chronic Allograft Nephropathy.

Non-Invasive Diagnosis for Acute Rejection Using Urinary mRNA Signature Reflecting Allograft Status in Kidney Transplantation